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The World Health Organization’s “Guidelines for Drinking-water Quality” has identified 
safe drinking water as essential to health and a human right. Disinfection by chlorination is 
commonly used for drinking water purification in the United States, but the chlorine dose 
required to inactivate certain viruses remains unknown. One such virus is coxsackievirus. 
Coxsackievirus, along with other enteroviruses, causes a significant number of infections in the 
United States. These infections can prove fatal to those with relatively weak immune systems 
(children, the elderly, women in pregnancy, etc.). This research investigates the free chlorine 
exposure required to effectively inactivate coxsackievirus B5 in drinking water as a function of 
pH and temperature and to compare those values with the corresponding US Environmental 
Protection Agency regulations for enteric viruses as a group. It is hoped that this research will 
facilitate the improvement of water regulations and disinfection methods, thus pushing the 















My greatest discovery was that I needed God, and that I was nothing without him and that he 
loved me and showed his love by sending Jesus to save me. 
 Alexander Fleming 
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CHAPTER 1: INTRODUCTION 
 
Everyone who drinks of this water will be thirsty again, but whoever drinks of the water that I 
will give him will never be thirsty again. The water that I will give him will become in him a 
spring of water welling up to eternal life. 
Jesus, John 4:13-14 
 
In 2010, the United Nations declared that safe, clean drinking water is a basic human 
right and essential to human health. One critical treatment technology in providing safe drinking 
water is disinfection. There are several disinfection processes that can be used in drinking water 
purification (e.g. chlorine, ozone, and ultraviolet light), but the most common is free chlorine 
(World Health Organization [WHO], 2017). The United States Environmental Protection Agency 
(US EPA) also requires that a disinfection process (or a combination of disinfection processes) 
be part of drinking water plants and has specific regulations regarding free chlorine inactivation 
of various microbial contaminants (1991, 2006).  
The amount of exposure to free chlorine required to inactivate a pathogen is quantified by 
CT values. CT is calculated as the residual disinfectant concentration (mg/L) multiplied by the 
contact time (minutes). The inactivation of affected pathogens is described in terms of levels of 
log inactivation. This is determined by the logarithmic value of the fraction of surviving 
pathogens out of the original population. 
While free chlorine is a well-established method of disinfection, there remain some 
waterborne pathogens with unknown resistance to free chlorine. Among these are several 




have been detected in drinking water supplies that met treatment requirements, indicating that 
their resistance to disinfection is greater than that stipulated by current regulations (WHO, 2017). 
For this reason, coxsackievirus, an enterovirus, was included in the US EPA’s Contaminant 
Candidate List (CCL) 3 and 4 (US EPA, 2009, 2016).  
Previous studies have shown that coxsackievirus B5 (CVB5) is one of the most resistant 
enteroviruses to free-chlorine. Its required chlorine exposure exceeds the CT values listed in 
current US EPA regulations for corresponding levels of inactivation. It has also been noted that 
temperature and pH impact the effectiveness of free chlorine inactivation of CVB5 (Kahler et al., 
2010). While previous studies have shown that CVB5 inactivation is not achieved by current US 
EPA recommendations, its resistance had only been studied at limited temperature and pH 
conditions. 
In this study, the inactivation kinetics of CVB5 with free chlorine was investigated over a 
range of pH and temperature values relevant to drinking water. The inactivation kinetics with 
combined chlorine was also studied at a single pH and temperature point and compared to free 
chlorine kinetics under similar conditions. Experiments were also conducted using free chlorine 
to inactivate CVB5 up to a certain level, and then combined chlorine was introduced for the 
remainder of the experiment. This last study was performed to simulate the disinfection process 
used at some water treatment plants that practice sequential disinfection with free chlorine 
followed by combined chlorine resulting from ammonia addition. This is a common method used 
to lower the formation of regulated disinfection by-products while still providing a chlorine 
residual. The effect of these varying forms of chlorine on the CVB5 inactivation kinetics was 
thus evaluated under controlled, laboratory conditions. The next chapter presents a brief 




CHAPTER 2: PATHOGEN OF CONCERN 
 
One does not ask one who suffers: What is your country and what is your religion? One merely 
says: You suffer, that is enough for me. 
Louis Pasteur 
 
Coxsackievirus (CV) is of the enterovirus genus in the Picornaviridae family. It was first 
isolated from feces of paralyzed children in Coxsackie, New York in 1948 during a poliomyelitis 
epidemic. However, it was determined to be different from poliovirus when it was inoculated and 
studied in mice. As the virus was further studied, its variations were classified by letters (A or B) 
and numbers. CVA viruses cause hind limb paralysis in mice and flaccid paralysis in newborn 
mice, whereas CVB cause spastic paralysis in grown and newborn mice. There are several other 
syndromes that differentiate CVA from CVB and further classify the virus types. The syndromes 
associated with CVB5, which was used in this study, include mild paralytic disease with atrophy 
(Knipe et al., 2007).  
CVB5 has a viral structure similar to other enteroviruses. Enteroviruses are around 30 nm 
in diameter and have a nonenveloped, icosahedral protein capsid. The capsid is formed by 4 
proteins: VP1, VP2, VP3, and VP4. Since they do not have an envelope, coxsackieviruses are 
insensitive to organic solvents, such as ethanol. Their genetic material is a single strand of 
positive messenger RNA that is approximately 7.4 kilobases long (Romero, 2017). 
CVB5 is transmitted by the fecal-oral route, making it a pathogen of concern for drinking 
water. It is resistant to stomach acid, which allows it to pass through and multiply in the small 




cycle of CVB5 follows the same pattern as other enteroviruses: (1) The virus attaches to a 
cellular receptor of the host cell. (2) The virus’ VPg protein enters the cell and shuts down host 
cell protein synthesis. (3) The viral genome is translated in the host cell. (4) The genomic RNA 
of the virus replicates itself. (5) The virions are assembled. (6) The virions are released by lysis 
of the host cell and are free to infect other cells (Romero, 2017).  
While most enteroviruses do not pose a significant threat to healthy adults, they can result 
in serious illness in infants and the immunocompromised. Some of the recognizable syndromes 
of coxsackievirus include aseptic meningitis, paralysis, hepatitis, respiratory illness, and 
“common cold” symptoms (Knipe et al., 2007). The most well known syndrome of 
coxsackievirus is hand-foot-mouth disease (see Figure 2.1), commonly known to spread through 
public schools (Olentangy Local School District, 2017).  However, this syndrome is associated 
with CVA, not CVB (Knipe et al., 2007).  
 
 




CHAPTER 3: MATERIALS AND METHODS 
 
The more I study nature, the more I stand amazed at the work of the Creator. Science brings men 
nearer to God. 
Louis Pasteur 
 
3.1 Virus Propagation and Viability Assessment 
Buffalo green monkey kidney (BGMK) cell monolayers were used to propagate the virus 
and assess its viability. BGMK cell monolayers were prepared in accordance with the methods 
described in the USEPA Manual of Methods for Virology (/600/4-84/013, 2001). BGMK cells 
were obtained from QUIDEL (San Diego, CA). Upon arrival, the cell culture was added to cell 
media pre-warmed to 37˚C. Sufficient cell media was added to give a total volume of 20 mL in a 
175 cm2 tissue-culture flask. Cell media was made with a 50/50 mixture of MEM (with Hank’s 
salts and L-glutamine, without sodium bicarbonate), Leibovitz’s L-15 (with L-glutamine), 0.75 g 
sodium bicarbonate per liter, 10% by volume fetal bovine serum (FBS), 1% by volume 
penicillin/streptomycin antibiotics, and 0.1% by volume Amphotericin B. This cell suspension 
was incubated at 37˚C until 80-90% confluence was observed. The cells were then propagated in 
new cell culture flasks. Some cells were added to media with DMSO (10% by volume of media), 
frozen (first 30 minutes at 0-4˚C, then overnight at -80 ˚C), and stored in liquid nitrogen for 
future use. 
Coxsackievirus B5 (CVB5) Faulkner (VR-185) was obtained from American Type 
Culture Collection (ATCC, Virginia). Cell lines were prepared and allowed to reach 
approximately 90% confluence before viral inoculation (2 to 6 days after preparation). On the 




(same recipe as cell media, except with 2% by volume FBS instead of 10%). Then 50 µL of virus 
stock was added to each 175 cm2 flask. Flasks were incubated at 37˚C until cytopathogenic effect 
was observed (approximately 2 days after viral inoculation). The flasks were then put through 3 
freeze-thaw cycles, after which the cell suspension was collected and centrifuged at 1000 rpm for 
10 minutes. The supernatant was collected and added to new cell lines to further propagate the 
virus, and the pellet was discarded. Once a sufficient amount of infected cells and virus was 
obtained, the monolayers were put through 3 freeze-thaw cycles. The cell suspension was 
collected and centrifuged at 1000 rpm for 10 minutes, and the supernatant was collected. A 
Millipore Stericup (0.22µm pore size) was used to remove organic matter in the supernatant. The 
supernatant was then purified using Amicon Cell virus purification (a Millipore ultrafiltration 
disc was used with a 300 KDa pore size).   
CVB5 viability was assessed by agar overlay plaque assay with BGMK cell monolayers. 
At least 2 days before the plaque assay, BGMK cells were passed to 25 cm2 tissue culture flasks 
and allowed to grow until approximately 95-100% confluence was observed. When preparing the 
plaque assay, virus suspensions were serially diluted in dilution media (same recipe as cell media 
but with no FBS). Then 0.8 mL of virus suspension was inoculated onto the cell monolayer for 
90 minutes at room temperature with slight mixing provided by a tilting plate set to a low speed 
and tilting angle. After this, 9 mL of an overlay medium was added to the flask and mixed with 
the prior virus suspension. The overlay medium consisted of 83 mL of 2X MEM, 1 mL of 
magnesium chloride (1.00 M), 3 mL of FBS, 1 mL penicillin/streptomycin antibiotics (10,000 
units penicillin and 10 mg streptomycin/mL), 0.2 mL of Amphotericin B (250 µg/mL in 
deionized water), 6mL sodium bicarbonate (7.5%), 0.85 mL neutral red stock (0.33%), and 100 




Louis, MO). This recipe is for twenty, 25 cm2 flasks. The mixture in the flasks was allowed to 
harden in the dark since neutral red reacts with light such that it becomes lethal to the BGMK 
cells. Once hardened, the flasks were incubated upside down at 37˚C. Plaque formation was 
observed 2 - 7 days after the agar overlay. Flasks with 20 - 333 plaques were used for calculating 
the virus concentration (Vonder Haar, 2009).  
 
3.2 Free Chlorine Disinfection Experiments 
Two autoclaved, 50 mL reactors were used. Continuous mixing conditions were achieved 
by magnetic stirring. A recirculating water bath was used to maintain a steady temperature 
throughout the experiment. Experiments were performed at 5˚C, 15˚C, and 25˚C. The pH was 
monitored throughout the course of each experiment, and hydrochloric acid and sodium 
hydroxide were used to maintain the value within ± 0.05 units of the desired pH. Experiments 
were performed at pH 7, 8, 9, 9.5 and 10. The free chlorine stock was prepared in an autoclaved 
100 mL reactor by adding 0.5 mL of 5% sodium hypochlorite to 49.5 mL autoclaved nano-pure 
water.  
The two reactors were filled with 50 mL of 1 mM carbonate buffer solution (CBS), which 
consisted of 0.083 g sodium bicarbonate mixed in 1L of nano-pure water and autoclaved. One 
reactor was used to determine the initial chlorine concentration (Reactor A), and the second 
reactor was used to determine the chlorine and virus concentrations over the course of the 
experiment (Reactor B). At the start of the experiment, once the pH was adjusted in Reactor A, 
90 – 1600 µL of chlorine stock was added to achieve the desired chlorine concentration. A 
sample was taken 10-30 seconds after adding the chlorine (as soon as possible while allowing for 




the N,N-diethyl-p-phenylenediamine (DPD) colorimetric method (4500-Cl G. American Public 
Health Association [APHA] et al., 2012).  
The standard curve for the DPD colorimetric method was generated by measuring the 
concentration of a free chlorine stock using HACH (Loveland, CO) DR890 colorimeters. This 
known concentration was then compared with absorbance values of dilutions from an identically 
prepared free chlorine stock measured by the UV-1601 spectrophotometer. Since it was observed 
that the concentration of free chlorine in the stock degraded over time, the same stock could not 
be used for both the DR 890 and spectrophotometer readings, so two, identically prepared stocks 
were used. 
After the chlorine concentration of Reactor A was measured, 500 µL of CVB5 stock was 
added to Reactor B to achieve 104 – 106 viruses per mL and the pH was adjusted. An initial virus 
sample was taken, placed in a tube with quencher (2.48 g sodium thiosulfate pentahydrate in 100 
mL autoclaved nano-pure water), and stored in ice. This sample was used to determine the initial 
virus concentration N0. After this, the same volume of chlorine was added to Reactor B as was 
added to Reactor A. Time points in the experiment were measured as starting from this addition 
of chlorine. A chlorine sample was taken 10-30 seconds after the chlorine addition and analyzed 
by the UV-1601 spectrophotometer and the DPD colorimetric method to determine the chlorine 
demand of the virus stock. Additional chlorine samples were taken and analyzed throughout the 
experiment. Virus samples were also collected and stored in tubes with quencher on ice for 
analysis by plaque assay. The time at which each sample was collected was recorded so that 






3.3 Combined Chlorine Disinfection Experiments 
Three autoclaved, 50 mL reactors were used. Experiments were performed at 15˚C and 
pH 9. The temperature and pH were controlled using the methods described in section 3.2. The 
free chlorine stock was prepared as described in section 3.2, although the final volume of stock 
could be lowered by decreasing the components proportionally. The ammonia stock was 
prepared in an autoclaved 100 mL reactor by adding 0.766 g of NH4Cl to 100 mL of autoclaved, 
nano-pure water (this solution is good for 2 weeks if stored at 5˚C).  
The three reactors were filled with 1 mM carbonate buffer solution (CBS), prepared as 
described in section 3.2. One reactor contained the CBS and chlorine stock (Reactor A). The 
second reactor contained CBS and ammonia stock (Reactor B). Reactor B was then placed on a 
magnetic stirring plate, and the speed was set to the lowest setting (approximately 60 revolutions 
per minute). The contents of Reactor A were transferred to Reactor B drop by drop using a 1mL 
pipet. The concentrations of chlorine and ammonia could be adjusted based on the desired final 
concentration of monochloramine as long as the molar ratio was kept as 3N:1Cl2. After all of the 
contents of Reactor A were transferred to Reactor B, a UV-2700 spectrophotometer was used to 
determine what chloramine species were present in Reactor B. The absorbance was measured 
over a range of wavelengths from 400-200 nm, and any peaks observed were noted. 
(Monochloramine is absorbed at 243 nm, dichloramine at 294 and 297 nm, and trichloramine at 
336 nm.) The third reactor (Reactor C) was used to determine the initial concentration of CVB5, 
so it contained CBS (equal to the volume in Reactor B at the start of the experiment) and the 
same volume of CVB5 as was added to Reactor B. (In some experiments, Reactor C was half the 
volume of Reactor B. In this instance, the volume of CVB5 added to Reactor C was half that 




At the start of the experiment, the pH was adjusted in Reactors B and C. The pH of the 
reactors was monitored throughout the course of the experiment, although between pH 
measurements, the pH meter had to soak in bleach for 10 minutes to inactivate any virus attached 
to it and then soak in its storage solution. An initial monochloramine sample was then taken from 
Reactor B, and its chlorine concentration was measured by the UV-1601 spectrophotometer 
using the DPD colorimetric method (4500-Cl G. APHA et al., 2012). The standard curve for the 
DPD colorimetric method was generated by measuring the absorbance of a monochloramine 
stock using a UV-2550 spectrophotometer and calculating the monochloramine concentration 
using the Beer-Lambert law, ABS = εlC, where ABS is the absorbance, ε is the molar 
absorptivity of monochloramine at 243 nm (461 M-1cm-1), l is the path length (1 cm), and C is 
the concentration (M). This known concentration was then compared with absorbance values of 
dilutions of the same monochloramine stock measured by the UV-1601 spectrophotometer.  
A volume of the CVB5 stock was then added to Reactor B (to achieve 104 – 106 viruses 
per mL) to start the inactivation experiment. Time points in the experiment were measured as 
starting from this addition of CVB5. Additional chlorine samples were taken and analyzed 
throughout the experiment. Virus samples were also collected, placed in a tube with quencher 
(prepared as described in section 3.2), and stored in ice for analysis by plaque assay. The time at 
which each sample was collected was recorded so that comparisons could be made later between 
the CT values and virus inactivation. CVB5 was also added to Reactor C, and an initial virus 
sample was taken and stored in a tube with quencher on ice; this sample was used to determine 
the initial virus concentration N0. The time at which CVB5 was added to Reactor C was noted, 
and Reactor C was left in the water bath for the same amount of time as the duration of the 




the final time point of Reactor B’s experiment, a final virus sample was taken from Reactor C to 
determine if there was any alteration in the virus concentration over time without exposure to 
chlorine. 
For the results and discussion of these experiments, see Appendices B and C. 
 
3.4 Sequential Free Chlorine/Combined Chlorine Disinfection Experiments 
Two autoclaved, 50 mL reactors were used. Continuous mixing conditions were achieved 
by magnetic stirring. Experiments were performed at 15˚C and pH 9 using the same temperature 
and pH control methods described in section 3.2. The experiment was conducted following the 
procedure described in section 3.2. The only differences were that 700 µL of chlorine stock was 
added to Reactor A and 1670 µL of CVB5 stock was added to Reactor B.  
Prior to the experiment, the CT value required to achieve 2-log removal of CVB5 with 
free chlorine was estimated. Once this CT value was reached, ammonia was added to Reactor B 
to switch the inactivating agent from free chlorine to combined chlorine. This was achieved by 
increasing stirring so that the speed was as fast as possible without creating a vortex. Then a 
volume of the ammonia stock (prepared as described in section 3.3) was quickly added to 
Reactor B. The time at which ammonia was added to Reactor B was noted. The volume of 
ammonia stock added was calculated based on the free chlorine concentration in Reactor B at 
that time, the volume of liquid in the reactor, and the amount of ammonia required to maintain a 
3N:1Cl2 molar ratio. As soon as possible, while allowing a few seconds for mixing, a combined 
chlorine sample was then taken from Reactor B, and its chlorine concentration was measured 
using the method described in section 3.3. A virus sample was also collected and stored in a tube 




Once this was done, a UV-2700 spectrophotometer was used to determine what 
chloramine species were present in Reactor B following the procedure described in section 3.3. 
Additional combined chlorine samples were taken and analyzed throughout the experiment. 
Virus samples were also collected, placed in a tube with quencher, and stored in ice for analysis 
by plaque assay. The time at which each sample was collected was recorded so that comparisons 
could be made later between the CT values and virus inactivation. 




CHAPTER 4: RESULTS AND DISCUSSION 
 
The significance and joy in my science comes in those occasional moments of discovering 
something new and saying to myself, ‘So that’s how God did it.’ My goal is to understand a little 
corner of God’s plan. 
Henry F. Schaefer III 
 
Experiments were performed at 5˚C, 15˚C, and 25˚C and pH of 7, 8, 9, and 10 in reactors 
containing carbonate buffer solution (CBS). The raw data from these experiments can be seen in 
Appendix A. Triplicate experiments at each pH and temperature condition showed that the 
inactivation kinetics varied with temperature and pH. Greater resistance to free chlorine was 
observed at higher pH values, as can be seen in Figures 4.1, 4.2, and 4.3. CVB5 also displayed 
greater resistance to free chlorine at lower temperatures, as can be seen in Figures 4.4, 4.5, 4.6, 
and 4.7. It can also be seen from the figures that the inactivation curves displayed first order 
kinetics. This is consistent with the results from previous studies (Black et al., 2009; Cromeans et 
al., 2010; Kahler et al., 2010). 
Two additional experiments were performed at pH 9.5 and temperatures of 5˚C and 25˚C 
to observe the inactivation kinetics at an intermediate pH value. The raw data from these 
experiments can also be seen in Appendix A. These experiments, however, were not performed 
in triplicate due to the limited amount of virus stock left. The inactivation at pH 9.5 followed the 
pattern observed in the prior experiments discussed above, demonstrating that the trend is 






Figure 4.1 CVB5 Inactivation Kinetics with Free Chlorine at 25˚C 
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Figure 4.3 CVB5 Inactivation Kinetics with Free Chlorine at 5˚C 
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Figure 4.5 CVB5 Inactivation Kinetics with Free Chlorine at pH 9 
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Figure 4.7 CVB5 Inactivation Kinetics with Free Chlorine at pH 7 
 
A second CVB5 stock was made (CVB5 Stock Kelley), and free chlorine inactivation 
experiments were run at pH 9.0 and temperature 15˚C. The raw data from these triplicate 
experiments can also be seen in Appendix A. The inactivation kinetics of this stock were similar 
to the kinetics of Stock A. However, as shown in Figure 4.8, CVB5 Stock Kelley was slightly 
less resistance to free chlorine than CVB5 Stock A. This was not of concern because the free 
chlorine inactivation kinetics had been determined with CVB5 Stock A, which showed greater 
resistance, so the kinetics reported by this study were conservative. Despite this slight difference, 
the two stocks were sufficiently comparable for CVB5 Stock Kelley to be used in the 
experiments with combined chlorine, as discussed in Appendix C. This was done since a limited 
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Figure 4.8 Inactivation Kinetics of CVB5 Stock A vs. Stock Kelley at pH 9 and 15˚C 
 
The Chick-Watson disinfection model was used to represent the inactivation kinetics of 
CVB5 with free chlorine (see Equation 4.1): 
It was found that the inactivation displayed a lag-phase in the initial portion of the graphs 
(from a CT of 0.0 to a CTlag) during which limited inactivation takes place. This lag phase 
resulted in an intercept N with the y-axis when extended a first order linear regression for N/N0 < 
0.1. The average N1/N0 value for all experiments in Figures 4.1 – 4.7 was found to be 2.0 for the 
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Where N is the concentration of CVB5, N0 is the initial concentration of CVB5, N1 is the 
extrapolated concentration of CVB5 at time zero as described above, k is the inactivation rate 
constant, C is the concentration of free chlorine (mg/L Cl2), T is the time of exposure (min), and 
CTlag is the lag phase exposure. 
The results from the inactivation experiments were graphed, following the Chick-Watson 
model, as log(N/N0) CVB5 and CT (min*mg/L Cl2) (as shown in Figures 4.1 – 4.8). A linear 
regression for the data was plotted using Microsoft Excel, and the inactivation coefficient (k) 
was calculated by determining the slope of the best-fit line with the y-intercept set to log(2) (or 
log[N1/N0]). The average of the slope values from each set of triplicate experiments was 
calculated and recorded in Table 4.1 and displayed in Figure 4.9. Note that the absolute values of 
the slopes are shown in Table 4.1 for ease of future comparisons, although the actual values of 
the slopes are negative. 
 
Table 4.1 Average Absolute Values of Slopes of CVB5 Inactivation with Free Chlorine 
  Temperature (˚C) 
pH 5 15 25 
7 0.52 0.86 1.94 
8 0.24 0.43 0.92 
9 0.070 0.12 0.23 
9.5 0.033  NA 0.16 






Figure 4.9 Average k Values from Inactivation Experiments as a Function of pH and Temperature 
 
Since the pKa of hypochlorous acid and the hypochlorite ion is known (see Table 4.2), the 
impact of both forms of chlorine on the inactivation kinetics could be analyzed. Faster 
inactivation was observed at lower pH values (closer to or below the pKa of hypochlorous acid), 
where there is a greater percentage of hypochlorous acid than hypochlorite. From this, it was 
concluded that hypochlorous acid is a stronger disinfectant than the hypochlorite ion. However, 
the inactivation rate observed at pH 10, more than 2 pH units above the pKa of hypochlorous 
acid, was faster than that resulting from exposure to the small fraction of hypochlorous acid. This 
indicates that the hypochlorite ion is also able to inactivate CVB5, although its inactivation 























Table 4.2 pKa Values of Hypochlorous Acid (Black and Veatch Corporation, 2009) 
pKa 7.75 7.63 7.54 
T (˚C) 5 15 25 
 
Based on this information, a mathematical model was built to represent the inactivation 
kinetics over the range of pH and temperature values studied (see Equation 4.3). Since both 
hypochlorous acid and the hypochlorite ion are capable of inactivating CVB5, their individual 
impacts were incorporated into the equation for the overall inactivation coefficient. 
 
k = k!α!,! + k!α!,!α!,! Equation 4.3 
 
Where k0 corresponds to the inactivation coefficient of hypochlorous acid and k1 to the 
inactivation coefficient of the hypochlorite ion. The α0,C and α1,C values correspond to the molar 






 Equation 4.4 
!!,! = !!,![H!]!!!,! Equation 4.5 
 
It was observed that the inactivation coefficient continued to decrease at high pH values 
instead of stabilizing when the hypochlorite ion was the main inactivating agent. It was expected 
that the coefficient would stabilize once the percentage of hypochlorite relative to the total 




influencing the inactivation power of the hypochlorite ion at high pH values. For this reason, α0,V 
was added to the overall k equation as a multiplier of the hypochlorite inactivation coefficient, as 
shown in Equations 4.3 and 4.6. This term could relate to the resistance of the virus’ amine 
groups. However, additional experimentation at higher pH values would be required to validate 





 Equation 4.6 
 
The pKa value for hypochlorous acid/hypochlorite ion, pKa,C, and its relationship with 
temperature and pH was already known from White’s Handbook of Chlorination and Alternative 
Disinfectants (Black and Veatch Corporation, 2009). However, the pKa relating to α0,V, pKa,V, 
was unknown. In addition to this, the inactivation coefficients relative to hypochlorous acid, k0, 
and the hypochlorite ion, k1, were also unknown. The experimental data obtained from the work 
in this study (average inactivation coefficients, pH, and temperature conditions) were used to 
calculate these unknown values with Sigma Plot. The results of these calculations are shown in 
Table 4.3 below.  
 
Table 4.3 Coefficients Pertaining to the Inactivation Model 




5oC 7.76 9.79 1.41±0.04 0.0785±0.0237 
15oC 7.63 9.44 2.59±0.12 0.251±0.053 





It was found that the Arrhenius equation could be used to represent the temperature 
dependence of the inactivation coefficients (see Equations 4.7 and 4.8), where R=8.315 J/(mol 
K) is the ideal gas law constant, and T is temperature in Kelvin. The coefficients in these 




!"  Equation 4.7 
!! = 2.95×10!!×!!
!!,!"#
!"  Equation 4.8 
 
Since the slopes in Table 4.1 were calculated using a log scale graph but the model 
utilizes a natural log (see Equation 4.1), the average values of the slopes were converted to a 
natural log scale (by multiplying by 2.303, or ln[10]) as shown in Table 4.4. Note that the 
absolute values of the slopes are depicted for ease of future calculations, although the actual 
slopes are negative. 
 
Table 4.4 Absolute Value of CVB5 Inactivation Slopes Adjusted for Natural Log 
  Temperature (˚C) 
pH 5 15 25 
7 1.20516 1.97774 4.45684 
8 0.54236 1.00142 2.12974 
9 0.16121 0.27505 0.52524 
9.5 0.07648  NA 0.35862 
10 0.02956 0.05896 0.15760 
 
The mathematical model discussed above was used to calculate inactivation coefficients 




coefficients were compared to the average experimental coefficients to determine how accurately 
the model fit the data (see Figures 4.10, 4.11, and 4.12). 
 








pH 5 15 25 
7 1.16092 2.30853 4.37978 
8 0.52612 0.89497 1.50335 
9 0.11862 0.16287 0.24272 
9.5 0.06044 NA 0.09291 
10 0.02899 0.02626 0.03309 
 
 






















Figure 4.11 Calculated Inactivation Coefficients vs. Experimental at 15˚C 
 
 





































As can be seen in the figures above, the model presented in Equation 4.3 accurately 
represents the inactivation coefficients at low pH and low temperature values. However, at 
higher pH and high temperature values, the model does not match the experimental inactivation 
coefficients as accurately. Further work must be done to determine why this discrepancy exists 
and to create a model that better correlates with the observed behavior.  
The current US EPA regulations for inactivating viruses with free chlorine were listed in 
Table 4.6 below. These regulations were compared with the inactivation kinetics obtained in this 
study in Figures 4.13, 4.14, and 4.15 below. As can be seen in the figures below, the US EPA 
regulations consistently fell short of the CT values required to adequately inactivate CVB5 under 
the pH and temperature conditions tested (pH 7 – pH 10, 5˚C – 25˚C). 
 




2 3 4 
 
pH pH pH 
Temperature (˚C) 6.0 - 9.0 10 6.0 - 9.0 10 6.0 - 9.0 10 
0.5 6 45 9 66 12 90 
5 4 30 6 44 8 60 
10 3 22 4 33 6 45 
15 2 15 3 22 4 30 
20 1 11 2 16 3 22 






Figure 4.13 Experimental Inactivation of CVB5 with Free Chlorine vs. US EPA Regulations at 25˚C 
 
 


















CT (mg Cl2*min/L) 
Experimental vs. US EPA at T 25˚C pH 10, T 25, 5 
pH 10, T 25, 6 
pH 10, T 25, 7 
pH 9, T 25, 7 
pH 9, T 25, 5 
pH 9, T 25, 6 
pH 8, T 25, 1 
pH 8, T 25, 2 
pH 8, T 25, 3 
pH 7, T 25, 1 
pH 7, T 25, 3 
pH 7, T 25, 4 
EPA pH 6-9 





















CT (mg Cl2*min/L) 
Experimental vs. US EPA at T 15˚C 
pH 10, T 15, 3 
pH 10, T 15, 4 
pH 10, T 15, 5 
pH 9, T 15, 1 
pH 9, T 15, 2 
pH 9, T 15, 3 
pH 8, T 15, 1 
pH 8, T 15, 2 
pH 8, T 15, 3 
pH 7, T 15, 1 
pH 7, T 15, 2 
pH 7, T 15, 3 
EPA pH 6-9 


























CT (mg Cl2*min/L) 
Experimental vs. US EPA at T 5˚C 
pH 10, T 5, 1 
pH 10, T 5, 2 
pH 10, T 5, 3 
pH 9, T 5, 1 
pH 9, T 5, 2 
pH 9, T 5, 3 
pH 8, T 5, 1 
pH 8, T 5, 2 
pH 8, T 5, 3 
pH 7, T 5, 1 
pH 7, T 5, 2 
pH 7, T 5, 3 
EPA pH 6-9 




CHAPTER 5: CONCLUSIONS 
 
Le premier regard de l’homme jeté sur l’univers n’y découvre que variété, diversité, multiplicité 
des phénomènes. Que ce regard soit illuminé par la science, - par la science qui rapproche 
l’homme de Dieu, - et la simplicité et l’unité brillent de toutes parts. 
Louis Pasteur 
 
The kinetics of the inactivation of CVB5 with free chlorine observed in this study follows 
trends consistent with previous studies (Black et al., 2009; Cromeans et al., 2010; Kahler et al., 
2010). The inactivation curves displayed first order kinetics, and greater resistance to free 
chlorine was observed at higher pH values and lower temperatures.  
The Chick-Watson disinfection model was used to represent the inactivation kinetics of 
CVB5 with free chlorine (see Equation 5.1). A lag phase was observed in the inactivation data, 





1                             if  !" < !"!"#
!!
!!
!!!"#               if  !" > !"!"#  Equation 5.1 
with  !!!! = 2.0 Equation 5.2 
 
A mathematical model was built to represent the inactivation coefficient (see Equation 
5.3).  It was found that both hypochlorous acid and the hypochlorite ion are capable of 
inactivating CVB5, although hypochlorous acid displays greater inactivation power. A continued 




impacting the coefficient. This was represented by α0,V, which may correspond to the resistance 
of the CVB5 amine groups. However, additional tests at higher pH values would be required to 
confirm the cause of the observed decrease in the coefficient. 
 
k = k!α!,! + k!α!,!α!,! Equation 5.3 
 
The Arrhenius equation was used to model the temperature dependence of the 





!"  Equation 5.4 
!! = 2.95×10!!×!!
!!,!"#
!"  Equation 5.5 
 
The inactivation kinetics obtained in this study were compared with the US EPA drinking 
water regulations. It was found that the regulations consistently fell short of the required CT 
values observed in this study at the pH and temperature conditions tested (pH 7 – pH 10, 5˚C – 
25˚C). The inactivation kinetics and mathematical model obtained in this study reflect the 
resistance of CVB5 to free chlorine over a range of pH and temperature values that are relevant 
to drinking water treatment. This information can be used to update the US EPA regulations to 
improve drinking water safety in accordance with the World Health Organization’s goals. 
Molecular biology work is required to fully understand the mechanism of CVB5 
inactivation with free chlorine. This additional work could also reveal the causalities of the 




obtained from such future work can be used to further inform updates to drinking water 
regulations. This would ensure safe water quality for the public, including the 
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APPENDIX A: RAW DATA OF FREE CHLORINE EXPERIMENTS 
 
Note: In CT vs. Time tables, the row highlighted in yellow is a theoretical time point of when 
curve A intersects curve B. It is not an actual data point. 
Table A.1 Experimental Conditions 
02-May-18  Date 
25  Temperature (˚C) 
10.00  pH 
210 
Virus 
 Volume of Chlorine Stock Added (µL) 
100 µL of CVB5 Stock A 
 
Table A.2 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.105 2.0 2.0067 0.00 
0.233 0.270 2.0 2.5800 0.53 
5.550 0.184 2.0 1.7582 11.18 
10.740       19.34 
10.783 0.180 2.0 1.7200 19.42 
17.433 0.175 2.0 1.6722 31.14 
23.833 0.172 2.0 1.6436 42.17 
30.017 0.168 2.0 1.6054 52.59 
 
Table A.3 Raw pH Data 
pH 9.96 9.98 10.03 10.03 9.97 9.97 10.00 10.02 
Time 0.00 1.00 6.33 12.88 18.83 24.42 24.67 Final 
 
Table A.4 Raw Virus Inactivation Data 
Time Viability at 10^-x dilution N N/No Log N/No CT 
[min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
0.00     189+ 51 7   70125 1.000000 0.00 0.00 
5.00   TNTC 148 22     20350 0.290196 -0.54 10.19 
10.07 TNTC 268 22 0     3685 0.052549 -1.28 18.39 
17.00 179+ 47 4 0     646.25 0.009216 -2.04 30.38 
23.00 51 10 1       70.125 0.001000 -3.00 40.74 
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Figure A.1 Chlorine vs. Time Graph 
	














































Table A.5 Experimental Conditions 
20-May-18  Date 
25  Temperature (˚C) 
10.00  pH 
210 
Virus 
 Volume of Chlorine Stock Added (µL) 
300 µL of CVB5 Stock A 
 
Table A.6 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.179 2.0 1.7105 0.00 
0.333 0.160 2.0 1.5289 0.54 
0.776       1.17 
5.033 0.135 2.0 1.2900 6.70 
10.917 0.125 2.0 1.1945 14.00 
22.800 0.110 2.0 1.0511 27.55 
33.350 0.100 2.0 0.9556 38.37 
44.850 0.091 2.0 0.8696 49.01 
56.033 0.083 2.0 0.7931 58.30 
 
Table A.7 Raw pH Data 
pH 10.05 10.04 10.05 10.03 10.04 10.04 10.02 10.01 9.99 9.97 10.04 10.04 10.02 10.02 
Time 0.00 1.58 3.30 6.83 9.98 12.82 20.95 24.83 39.45 42.50 44.50 47.13 55.20 57.77 
 
Table A.8 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0.00     TNTC 37 0   50875 1.000000 0.000 0.000 
1 2.70   TNTC TNTC 22     30250 0.594595 -0.226 3.697 
2 6.42   TNTC 145 26     27844 0.547297 -0.262 8.456 
3 12.37   TNTC 11 7     5569 0.109459 -0.961 15.734 
4 24.47 TNTC 51 8       701 0.013784 -1.861 29.334 






Figure A.3 Chlorine vs. Time Graph 
	













































Table A.9 Experimental Conditions 
07-Jun-18  Date 
25  Temperature (˚C) 
10.00  pH 
400 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.10 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.272 2.0 2.5991 0.00 
0.267 0.253 2.0 2.4176 0.67 
1.733 0.203 2.0 1.9398 3.87 
2.034 
   
4.44 
4.900 0.184 2.0 1.7582 9.78 
8.133 0.171 2.0 1.6340 15.46 
13.400 0.153 2.0 1.4620 24.00 
21.067 0.135 2.0 1.2900 34.98 
32.933 0.112 2.0 1.0702 49.11 
41.500 0.100 2.0 0.9556 57.49 
46.933 0.093 2.0 0.8887 62.14 
55.633 0.083 2.0 0.7931 68.65 
 
Table A.11 Raw pH Data 
Time 0.00 1.73 3.50 7.32 10.08 15.97 20.12 23.75 27.65 31.68 35.15 36.60 48.90 53.30 57.12 
pH 10.04 10.00 10.02 10.01 9.99 9.98 9.98 9.98 9.98 9.97 9.95 10.01 10.00 9.98 9.98 
 
Table A.12 Raw Virus Inactivation Data 
 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0.00   TNTC TNTC 91 30 8 125125 1.000000 0.00 0.00 
1 3.90 TNTC TNTC TNTC 73 9   100375 0.802198 -0.10 7.95 
2 7.12 TNTC TNTC 294 30     40425 0.323077 -0.49 13.71 
3 12.30 TNTC TNTC 120 28     16500 0.131868 -0.88 22.28 
4 19.97 TNTC 104 37 10     1430 0.011429 -1.94 33.50 
5 31.97 42 10 2       57.75 0.000462 -3.34 48.08 
6 40.48 28 1         38.5 0.000308 -3.51 56.57 
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Figure A.5 Chlorine vs. Time Graph 
	














































Table A.13 Experimental Conditions 
11-Jun-18  Date 
25  Temperature (˚C) 
10.00  pH 
400 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.14 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0.000 0.241 2.0 2.3029 0.00 
0.200 0.228 2.0 2.1787 0.45 
1.733 0.212 2.0 2.0258 3.70 
2.594 
   
5.40 
5.017 0.196 2.0 1.8729 10.11 
9.583 0.181 2.0 1.7296 18.61 
13.450 0.173 2.0 1.6531 25.43 
20.933 0.159 2.0 1.5194 37.69 
32.783 0.140 2.0 1.3378 54.85 
40.967 0.130 2.0 1.2422 65.25 
57.967 0.110 2.0 1.0511 83.65 
 
Table A.15 Raw pH Data 
Time 0.00 2.60 8.27 8.95 11.42 14.67 22.97 31.40 39.13 46.83 
pH 9.97 9.97 9.95 10.02 10.04 10.03 10.00 10.00 9.98 9.93 
 
Table A.16 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0.00   TNTC TNTC 123 13 3 169125 1.000000 0.00 0.00 
1 4.08 TNTC TNTC TNTC 52 15   71500 0.422764 -0.37 8.31 
2 6.97 TNTC TNTC TNTC 38     52250 0.308943 -0.51 13.80 
3 12.48 TNTC TNTC 42 8     5775 0.034146 -1.47 23.76 
4 19.95 273 41 8 2     470 0.002776 -2.56 36.15 





Figure A.7 Chlorine vs. Time Graph 
	














































Table A.17 Experimental Conditions 
13-Jun-18  Date 
25  Temperature (˚C) 
10.00  pH 
400 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.18 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0.000 0.258 4.0 4.9307 0.00 
0.233 0.248 4.0 4.7396 1.13 
2.817 0.215 4.0 4.1089 12.61 
3.037 
   
13.51 
5.117 0.207 4.0 3.9560 22.14 
7.383 0.201 4.0 3.8414 31.30 
10.750 0.193 4.0 3.6885 44.45 
14.050 0.186 4.0 3.5547 56.84 
18.083 0.179 4.0 3.4209 71.33 
20.717 0.175 4.0 3.3445 80.42 
25.167 0.168 4.0 3.2107 95.14 
 
Table A.19 Raw pH Data 
pH 10.03 10.03 10.01 9.99 9.99 
Time 0.00 9.83 13.27 23.05 26.90 
 
Table A.20 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0.00   TNTC TNTC TNTC 64   880000 1.000000 0.00 0.00 
1 4.03   TNTC TNTC 49 12   67375 0.076563 -1.12 17.67 
2 6.37 TNTC TNTC 160 28     22000 0.025000 -1.60 27.22 
3 9.70 TNTC 195 32 1     3541 0.004023 -2.40 40.41 
4 13.08 TNTC 110 8 1     1513 0.001719 -2.76 53.26 
5 15.90 72 21         99 0.000113 -3.95 63.57 





Figure A.9 Chlorine vs. Time Graph 
	

















































Table A.21 Experimental Conditions 
25-Jun-18  Date 
15  Temperature (˚C) 
10.00  pH 
1600 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.22 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0 0.303 12.0 17.3722 0.00 
0.250 0.290 12.0 16.6269 4.33 
1.650 0.294 12.0 16.8562 28.25 
2.975 
   
50.38 
3.083 0.288 12.0 16.5122 52.20 
6.583 0.284 12.0 16.2828 110.30 
9.050 0.267 12.0 15.3082 150.75 
11.317 0.279 12.0 15.9962 187.57 
13.217 0.276 12.0 15.8242 218.16 
 
Table A.23 Raw pH Data 
Time 0.00 1.65 4.37 9.00 10.00 
pH 9.99 10.01 10.04 10.05 10.06 
Note: Chlorine sample taken at 0.250 min was excluded from analysis because it was 
observed that chlorine samples taken within 17 seconds of adding the chlorine tended to show 
incomplete mixing of chlorine with CBS. The sample taken at 9.050 min was also excluded from 
analysis as inaccurate due to human error since the two chlorine samples following it displayed 
higher absorbance. 
Table A.24 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 94   1292500 1.000000 0.00 0.00 
1 4.15 TNTC TNTC 65 22     8938 0.006915 -2.16 70.00 
2 7.82 TNTC 78 13 1     1073 0.000830 -3.08 130.58 
3 10.02 132 24         182 0.000140 -3.85 166.49 
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Figure A.11 Chlorine vs. Time Graph 
	














































Table A.25 Experimental Conditions 
03-July-18  Date 
15  Temperature (˚C) 
10.00  pH 
800 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.26 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0 0.242 8.0 9.2499 0.00 
0.267 0.223 8.0 8.5237 2.45 
1.733 0.232 8.0 8.8677 15.72 
3.033 0.228 8.0 8.7148 27.16 
4.475 
   
39.51 
8.583 0.218 8.0 8.3325 74.55 
12.850 0.213 8.0 8.1414 110.30 
19.500 0.206 8.0 7.8739 164.79 
26.033 0.203 8.0 7.7592 216.87 
30.833 0.198 8.0 7.5681 254.25 
 
Table A.27 Raw pH Data 
Time 0.00 4.48 6.58 18.50 25.08 30.00 32.33 
pH 9.98 10.00 9.99 9.98 9.98 9.96 9.97 
Note: Chlorine sample taken at 0.267 min was excluded from analysis because it was 
observed in later experiments that chlorine samples taken within 17 seconds of adding the 
chlorine tended to show incomplete mixing of chlorine with CBS. 
 
Table A.28 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC 166 22 4 228250 1.000000 0.00 0.00 
1 4.32 TNTC TNTC TNTC 72     49500 0.216867 -0.66 38.17 
2 7.62 TNTC TNTC 67 4     9213 0.040361 -1.39 66.36 
3 11.78 TNTC 54 8 1     743 0.003253 -2.49 101.42 
4 18.33 45 2 0       62 0.000271 -3.57 155.34 
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Figure A.13 Chlorine vs. Time Graph 
	





















































Table A.29 Experimental Conditions 
16-July-18  Date 
15  Temperature (˚C) 
10.00  pH 
800 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.30 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0 0.274 8.0 10.4730 0.00 
0.250 0.252 8.0 9.6321 2.52 
1.983 0.220 8.0 8.4090 18.35 
2.208 
   
20.21 
5.067 0.212 8.0 8.1032 43.74 
8.167 0.207 8.0 7.9121 68.81 
12.350 0.201 8.0 7.6828 101.94 
15.700 0.197 8.0 7.5299 127.89 
19.967 0.193 8.0 7.3770 160.22 
22.45 0.192 8.0 7.3387 178.68 
24.717 0.188 8.0 7.1859 195.29 
 
Table A.31 Raw pH Data 
Time 0.00 3.45 9.82 13.67 17.20 25.80 
pH 10.02 10.01 10.01 10.01 10.01 10.00 
 
Table A.32 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 57   783750 1.000000 0.00 0.00 
1 3.27   TNTC TNTC 103 10   70813 0.090351 -1.04 28.97 
2 6.28 TNTC TNTC TNTC 58     79750 0.101754 -0.99 53.63 
3 9.60 TNTC TNTC 216 4     29700 0.037895 -1.42 80.25 
4 13.50 TNTC 159 11       2186 0.002789 -2.55 110.90 
5 17.02 TNTC 70         963 0.001228 -2.91 137.95 





Figure A.15 Chlorine vs. Time Graph 
	






















































Table A.33 Experimental Conditions 
09-July-18  Date 
5  Temperature (˚C) 
10.00  pH 
1600 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.34 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0 0.261 15.0 18.7052 0.00 
0.233 0.266 15.0 19.0635 4.46 
1.750 0.245 15.0 17.5585 32.87 
3.100 0.249 15.0 17.8452 57.35 
3.790 
   
69.56 
5.800 0.238 15.0 17.0569 104.89 
9.167 0.245 15.0 17.5585 164.03 
11.483 0.245 15.0 17.5585 204.71 
14.033 0.244 15.0 17.4869 249.46 
16.583 0.245 15.0 17.5585 294.20 
 
Table A.35 Raw pH Data 
Time 0.00 4.75 8.07 Approx. 17 
pH 10.02 10.03 10.01 9.97 
 
Table A.36 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC 174 36 0 367125 1.000000 0.00 0.00 
1 4.55 TNTC TNTC 259 42 1   46681 0.127154 -0.90 82.92 
2 7.48 TNTC TNTC 47 5 1   6463 0.017603 -1.75 134.46 
3 10.58 TNTC 184 7       2530 0.006891 -2.16 188.91 
4 13.03 TNTC 138 2       1898 0.005169 -2.29 231.91 





Figure A.17 Chlorine vs. Time Graph 
	














































Table A.37 Experimental Conditions 
12-July-18  Date 
5  Temperature (˚C) 
10.00  pH 
1000 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.38 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0 0.215 12.0 12.3268 0.00 
0.333 0.206 12.0 11.8108 4.03 
1.800 0.199 12.0 11.4095 21.17 
2.399 
   
27.92 
6.617 0.191 12.0 10.9508 74.87 
11.383 0.189 12.0 10.8361 127.16 
15.567 0.186 12.0 10.6641 172.38 
19.633 0.173 12.0 9.9188 215.73 
22.75 0.181 12.0 10.3774 248.57 
24.917 0.179 12.0 10.2628 271.19 
31.35 0.177 12.0 10.1481 337.43 
 
Table A.39 Raw pH Data 
Time 0.00 0.00 3.18 9.98 
pH 9.98 10.02 10.01 10.02 
 
Table A.40 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 48   660000 1.000000 0.00 0.00 
1 3.03   TNTC TNTC 145 15   199375 0.302083 -0.52 35.02 
2 8.02 TNTC TNTC TNTC 40     55000 0.083333 -1.08 90.32 
3 12.58 TNTC TNTC 72 23     9900 0.015000 -1.82 140.20 
4 16.85 TNTC 500 19       4744 0.007188 -2.14 186.12 
5 20.90 TNTC 228 6       3135 0.004750 -2.32 229.12 
6 23.93 TNTC                 260.95 




Figure A.19 Chlorine vs. Time Graph 
	























































Table A.41 Experimental Conditions 
23-July-18  Date 
5  Temperature (˚C) 
10.00  pH 
1000 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.42 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0 0.204 12.0 11.6961 0.00 
0.217 0.208 12.0 11.9255 2.57 
1.600 0.193 12.0 11.0655 18.54 
2.817 0.190 12.0 10.8935 31.95 
3.403 
   
38.22 
7.283 0.182 12.0 10.4348 79.45 
12.050 0.179 12.0 10.2628 129.29 
17.900 0.174 12.0 9.9761 189.27 
24.233 0.170 12.0 9.7468 252.76 
27.983 0.168 12.0 9.6321 289.65 
32.967 0.166 12.0 9.5174 337.89 
 
Table A.43 Raw pH Data 
Time 0.00 4.00 9.05 13.50 19.28 
pH 9.97 10.00 10.00 10.01 10.00 
 
Table A.44 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC 182 33   352000 1.000000 0.00 0.00 
1 4.00   TNTC TNTC 117 17   160875 0.457031 -0.34 44.60 
2 8.43   TNTC TNTC 41 10   56375 0.160156 -0.80 91.55 
3 13.28   TNTC 178 21     24475 0.069531 -1.16 142.04 
4 19.12 TNTC TNTC 24       3300 0.009375 -2.03 201.58 
5 25.38 77 59 6       459 0.001303 -2.89 264.12 
6 29.20 55 23         76 0.000215 -3.67 301.51 




Figure A.21 Chlorine vs. Time Graph 
	
























































Table A.45 Experimental Conditions 
08-Aug-18  Date 
25  Temperature (˚C) 
9.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.46 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min] 
 
Factor [mg/L] [mg*min/L] 
0 0.256 2.0 2.4462 0.00 
0.317 0.247 2.0 2.3602 0.76 
1.783 0.145 2.0 1.3856 3.40 
2.677 
   
4.47 
6.100 0.094 2.0 0.8982 8.20 
11.200 0.069 2.0 0.6593 12.70 
14.533 0.059 2.0 0.5638 15.08 
18.050 0.050 2.0 0.4778 17.19 
21.683 0.043 2.0 0.4109 19.02 
25.100 0.075 1.0 0.3583 20.46 
27.300 0.069 1.0 0.3297 21.27 
 
Table A.47 Raw pH Data 
Time 0.00 3.00 13.57 18.30 24.50 26.50 28.00 
pH 8.97 9.00 9.00 8.99 8.97 8.98 8.97 
 
Table A.48 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 76 9 1045000 1.000000 0.00 0.00 
1 2.83   TNTC TNTC 156 33   334125 0.319737 -0.50 4.66 
2 7.28 TNTC TNTC 154 8     21175 0.020263 -1.69 9.35 
3 12.32 TNTC 72 5       990 0.000947 -3.02 13.54 






Figure A.23 Chlorine vs. Time Graph 
	














































Table A.49 Experimental Conditions 
15-Aug-18  Date 
25  Temperature (˚C) 
9.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.50 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.189 5.0 4.5151 0.00 
0.333 0.161 5.0 3.8462 1.40 
1.567 0.140 5.0 3.3445 5.93 
1.921       7.07 
3.233 0.127 5.0 3.0339 11.32 
5.567 0.113 5.0 2.6995 18.45 
7.700 0.108 5.0 2.5800 24.52 
10.433 0.100 5.0 2.3889 31.71 
 
Table A.51 Raw pH Data 
Time 0.00 1.57 12.77 
pH 8.95 9.02 9.02 
 
Table A.52 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 45 107 618750 1.000000 0.00 0.00 
1 2.47   TNTC 269 36 1   43244 0.069889 -1.16 8.86 
2 4.25 TNTC 110 39 0     3438 0.005556 -2.26 14.49 
3 6.63 23 3 1 0     32 0.000051 -4.29 21.53 
 
Note: The plaque count in the control sample at dilution -5 was disregarded since its 




Figure A.25 Chlorine vs. Time Graph 
	

















































Table A.53 Experimental Conditions 
15-Oct-18  Date 
25  Temperature (˚C) 
9.00  pH 
300 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.54 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.226 3.0 3.2394 0.00 
0.383 0.189 3.0 2.7090 1.14 
1.883 0.161 3.0 2.3077 5.00 
2.386       6.10 
4.483 0.139 3.0 1.9924 10.69 
7.150 0.126 3.0 1.8060 16.13 
9.767 0.117 3.0 1.6770 21.06 
12.050 0.111 3.0 1.5910 25.06 
 
Table A.55 Raw pH Data 
Time 0.00 1.88 4.48 7.15 9.77 12.05 13.78 
pH 8.96 8.99 9.02 9.02 9.02 9.02 9.02 
 
Table A.56 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 69 50 948750 1.000000 0.00 0.00 
1 2.88   TNTC 273 130 3   37538 0.039565 -1.40 7.22 
2 5.53 TNTC 129 9 2     1774 0.001870 -2.73 12.88 
3 8.42 74 6 2 0     102 0.000107 -3.97 18.56 
 
Note: The plaque counts in the control sample at dilution -5 and sample 1 at dilution -3 




Figure A.27 Chlorine vs. Time Graph 
	















































Table A.57 Experimental Conditions 
10-Aug-18  Date 
15  Temperature (˚C) 
9.00  pH 
400 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.58 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.227 4.0 4.3383 0.00 
0.317 0.218 4.0 4.1663 1.35 
1.767 0.195 4.0 3.7267 7.08 
2.811       10.81 
5.000 0.176 4.0 3.3636 18.44 
8.483 0.164 4.0 3.1343 30.16 
11.817 0.156 4.0 2.9814 40.87 
14.800 0.154 4.0 2.9431 50.07 
17.767 0.146 4.0 2.7903 58.87 
20.283 0.143 4.0 2.7329 66.08 
 
Table A.59 Raw pH Data 
Time 0.00 1.77 4.03 13.78 19.00 21.27 
pH 8.96 9.04 9.05 9.05 9.05 9.05 
 
Table A.60 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 64   880000 1.000000 0.00 0.00 
1 2.92   TNTC TNTC 109 7   149875 0.170313 -0.77 11.18 
2 6.10 TNTC TNTC 89 0     12238 0.013906 -1.86 22.20 







Figure A.29 Chlorine vs. Time Graph 
	
















































Table A.61 Experimental Conditions 
20-Aug-18  Date 
15  Temperature (˚C) 
9.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.62 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.00 0.241 2.0 2.3029 0.00 
0.37 0.198 2.0 1.8920 0.77 
1.78 0.143 2.0 1.3665 3.11 
2.82       4.33 
4.93 0.115 2.0 1.0989 6.59 
8.62 0.094 2.0 0.8982 10.57 
17.40 0.067 2.0 0.6402 18.12 
26.47 0.100 1.0 0.4778 24.01 
36.58 0.078 1.0 0.3727 28.89 
46.30 0.062 1.0 0.2962 32.33 
57.60 0.048 1.0 0.2293 35.22 
68.95 0.038 1.0 0.1816 37.25 
 
Table A.63 Raw pH Data 
Time 0.00 1.78 6.57 11.27 19.38 27.78 38.20 39.25 39.70 40.72 51.50 52.87 59.50 
pH 8.95 8.99 8.99 9.01 8.99 8.99 8.96 8.94 8.95 8.97 8.92 8.96 8.95 
 
Table A.64 Raw Virus Inactivation Data 
Time Viability at 10^-x dilution N N/No Log N/No CT 
[min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
0     TNTC TNTC 47 28 646250 1.000000 0.00 0.00 
2.78     TNTC TNTC 38   522500 0.808511 -0.09 4.29 
6.25     TNTC 119 20   163625 0.253191 -0.60 7.93 
9.82     TNTC 48     66000 0.102128 -0.99 11.32 
18.53   TNTC 60 13     8250 0.012766 -1.89 18.35 





Figure A.31 Chlorine vs. Time Graph 
	














































Table A.65 Experimental Conditions 
27-Aug-18  Date 
15  Temperature (˚C) 
9.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.66 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.244 2.0 2.3316 0.00 
0.317 0.197 2.0 1.8825 0.67 
1.733 0.156 2.0 1.4907 3.13 
2.736       4.45 
5.850 0.116 2.0 1.1085 8.22 
10.300 0.094 2.0 0.8982 13.01 
18.633 0.072 2.0 0.6880 20.39 
28.700 0.054 2.0 0.5160 27.09 
31.867 0.098 1.0 0.4682 28.79 
35.817 0.090 1.0 0.4300 30.70 
 
Table A.67 Raw pH Data 
Time 0.00 1.73 3.67 5.00 7.38 17.85 27.80 33.07 35.82 37.42 
pH 8.97 9.01 9.05 9.04 9.02 9.02 8.99 8.99 8.97 8.98 
 
Table A.68 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC 237 57 6 554813 1.000000 0.00 0.00 
1 2.78     TNTC 208 28 1 286000 0.515489 -0.29 4.51 
2 6.93     TNTC 99 15   136125 0.245353 -0.61 9.45 
3 11.55   TNTC 200 39     40563 0.073110 -1.14 14.24 
4 19.75   TNTC 39 2     5363 0.009665 -2.01 21.24 
5 29.95 261 33 5       406 0.000732 -3.14 27.78 
6 33.07 81 10         99 0.000178 -3.75 29.40 





Figure A.33 Chlorine vs. Time Graph 
	














































Table A.69 Experimental Conditions 
13-Aug-18  Date 
5  Temperature (˚C) 
9.00  pH 
700 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.70 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.232 8.0 8.8677 0.00 
0.233 0.174 8.0 6.6507 1.81 
1.783 0.191 8.0 7.3005 13.33 
2.718       19.87 
3.167 0.178 8.0 6.8036 22.99 
9.367 0.173 8.0 6.6125 65.25 
16.033 0.167 8.0 6.3832 109.06 
19.083 0.164 8.0 6.2685 128.55 
22.767 0.158 8.0 6.0392 151.65 
26.550 0.157 8.0 6.0010 174.88 
 
Note: It was observed in experiments that chlorine samples taken within 17 seconds of 
adding the chlorine tended to show incomplete mixing of chlorine with CBS. 
 
Table A.71 Raw pH Data 
Time 0.00 1.17 5.50 11.17 14.67 18.23 21.00 21.90 24.28 28.35 
pH 8.96 9.02 9.10 9.05 9.00 8.95 8.94 8.96 9.00 8.99 
 
Table A.72 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC TNTC 167 9 2296250 1.000000 0.00 0.00 
1 4.13   TNTC TNTC 34 3   46750 0.020359 -1.69 29.68 




Figure A.35 Chlorine vs. Time Graph 
	





















































Table A.73 Experimental Conditions 
22-Aug-18  Date 
5  Temperature (˚C) 
9.00  pH 
400 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.74 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.253 4.0 4.8352 0.00 
0.367 0.223 4.0 4.2618 1.67 
1.900 0.192 4.0 3.6694 7.85 
2.398   
 
  9.61 
6.383 0.174 4.0 3.3254 23.25 
10.450 0.159 4.0 3.0387 36.59 
14.617 0.156 4.0 2.9814 49.65 
18.283 0.151 4.0 2.8858 60.67 
21.083 0.148 4.0 2.8285 68.80 
23.967 0.140 4.0 2.6756 76.91 
 
Table A.75 Raw pH Data 
Time 0.00   3.37 4.00 4.25 5.38 6.38 7.82 10.45 12.03 17.52 25.05 26.28 
pH 8.97 9.06 9.11 9.08 9.04 9.02 9.00 8.96 8.95 8.98 8.97 8.97 8.98 
 
Table A.76 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC TNTC 85 10 1168750 1.000000 0.00 0.00 
1 3.05   TNTC TNTC 239 29   328625 0.281176 -0.55 11.88 
2 7.48   TNTC 293 38 4   46269 0.039588 -1.40 26.92 
3 11.67   TNTC 52 3     7150 0.006118 -2.21 40.46 
4 15.92 TNTC 117 18       1609 0.001376 -2.86 53.61 
5 19.45 96 20 5       132 0.000113 -3.95 64.09 





Figure A.37 Chlorine vs. Time Graph 
	


















































Table A.77 Experimental Conditions 
03-Sept-18  Date 
5  Temperature (˚C) 
9.00  pH 
300 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.78 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.096 8.0 3.6694 0.00 
0.333 0.165 4.0 3.1534 1.14 
1.767 0.136 4.0 2.5991 5.34 
2.599       7.33 
5.433 0.116 4.0 2.2169 13.73 
12.217 0.101 4.0 1.9302 28.09 
16.650 0.094 4.0 1.7965 36.81 
22.783 0.088 4.0 1.6818 48.06 
32.717 0.077 4.0 1.4716 64.45 
37.983 0.075 4.0 1.4333 72.31 
 
Table A.79 Raw pH Data 
Time 0.00 3.17 8.33 14.75 19.08 25.92 35.70 36.48 40.55 
pH 8.95 9.00 9.00 9.00 9.00 9.00 8.96 8.98 9.01 
 
Table A.80 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 55 2 756250 1.000000 0.00 0.00 
1 3.02   TNTC TNTC 174 19   239250 0.316364 -0.50 8.29 
2 6.58   TNTC TNTC 66 7   90750 0.120000 -0.92 16.25 
3 13.47   266 46 4     4991 0.006600 -2.18 30.60 
4 17.97   83 10 2     1141 0.001509 -2.82 39.30 





Figure A.39 Chlorine vs. Time Graph 
	















































Table A.81 Experimental Conditions 
08-Aug-18  Date 
25  Temperature (˚C) 
8.00  pH 
150 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.82 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.204 2.0 1.9494 0.00 
0.350 0.136 2.0 1.2996 0.56 
1.733 0.075 2.0 0.7167 2.00 
2.567       2.47 
5.850 0.034 2.0 0.3249 4.10 
8.150 0.051 1.0 0.2437 4.94 
11.817 0.033 1.0 0.1577 5.93 
15.133 0.024 1.0 0.1147 6.53 
17.283 0.02 1.0 0.0956 6.83 
 
Table A.83 Raw pH Data 
Time 0.00 0.00 1.50 4.22 4.50 5.13 7.05 10.63 18.28 
pH 8.03 8.02 8.13 8.11 8.08 8.04 8.02 8.01 8.03 
 
Table A.84 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 53   728750 1.000000 0.00 0.00 
1 2.68   TNTC TNTC 57 4   78375 0.107547 -0.97 2.54 







Figure A.41 Chlorine vs. Time Graph 
	














































Table A.85 Experimental Data 
15-Aug-18  Date 
25  Temperature (˚C) 
8.00  pH 
150 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.86 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.203 2.0 1.9398 0.00 
0.333 0.126 2.0 1.2040 0.52 
1.567 0.068 2.0 0.6498 1.70 
2.138       2.01 
4.233 0.036 2.0 0.3440 3.06 
6.983 0.047 1.0 0.2246 4.07 
8.550 0.038 1.0 0.1816 4.51 
11.600 0.026 1.0 0.1242 5.13 
14.267 0.019 1.0 0.0908 5.50 
18.417 0.014 1.0 0.0669 5.88 
20.767 0.012 1.0 0.0573 6.02 
 
Table A.87 Raw pH Data 
Time 0.00 1.57 4.17 5.12 7.90 13.22 17.63 19.83 
pH 7.96 8.08 8.05 8.03 8.04 8.04 8.05 8.06 
 
Note: At time 19.83, the water level in the reactor was below the level required for an 
accurate pH measurement.  
 
Table A.88 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC 163 45 8 421438 1.000000 0.00 0.00 
1 2.40   TNTC 147 26 0   20213 0.047961 -1.32 2.15 
2 5.12 TNTC 82 15 1     1128 0.002675 -2.57 3.43 
3 7.90 129 17 4       177 0.000421 -3.38 4.34 
4 9.58 36 7 2       50 0.000117 -3.93 4.75 
	 78	
	
Figure A.43 Chlorine vs. Time Graph 
	














































Table A.89 Experimental Conditions 
24-Aug-18  Date 
25  Temperature (˚C) 
8.00  pH 
90 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.90 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.203 1.0 0.9699 0.00 
0.333 0.118 1.0 0.5638 0.25 
1.483 0.040 1.0 0.1911 0.67 
2.986       0.81 
4.933 0.008 1.0 0.0382 0.88 
7.567 0.008 1.0 0.0382 0.98 
 
Table A.91 Raw pH Data 
Time 0.00 1.48 2.42 3.83 Approx. 8 11.08 
pH 7.95 8.04 8.05 Fluctuate around 8 Fluctuate around 8 8.03 
 
Table A.92 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC TNTC 72 8 990000 1.000000 0.00 0.00 
1 2.42   TNTC TNTC 188 28   258500 0.261111 -0.58 0.78 
2 5.87 TNTC TNTC TNTC 122     167750 0.169444 -0.77 0.92 








Figure A.45 Chlorine vs. Time Graph 
	













































Table A.93 Experimental Conditions 
10-Aug-18  Date 
15  Temperature (˚C) 
8.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.94 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.253 2.0 2.4176 0.00 
0.267 0.204 2.0 1.9494 0.58 
1.983 0.132 2.0 1.2613 3.39 
2.723       4.22 
4.283 0.102 2.0 0.9747 5.94 
6.567 0.085 2.0 0.8122 8.22 
9.317 0.073 2.0 0.6976 10.65 
12.167 0.063 2.0 0.6020 12.83 
15.767 0.053 2.0 0.5065 15.18 
19.100 0.047 2.0 0.4491 17.01 
21.250 0.042 2.0 0.4013 18.03 
 
Table A.95 Raw pH Data 
Time 0.00 1.00 2.88 4.50 5.18 7.73 8.08 12.17 19.98 22.1 
pH 7.97 8.09 8.08 8.04 8.04 8.05 8.03 8.04 8.01 7.98 
 
Table A.96 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0   TNTC TNTC TNTC 87   1196250 1.000000 0.00 0.00 
1 2.88   TNTC 264 24 0   36300 0.030345 -1.52 4.40 
2 5.18 TNTC 245 13 3     3369 0.002816 -2.55 6.87 






Figure A.47 Chlorine vs. Time Graph 
	














































Table A.97 Experimental Conditions 
20-Aug-18  Date 
15  Temperature (˚C) 
8.00  pH 
150 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.98 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.206 2.0 1.9685 0.00 
0.433 0.133 2.0 1.2709 0.70 
1.700 0.082 2.0 0.7836 2.04 
3.035       2.78 
5.233 0.041 2.0 0.3918 3.76 
8.633 0.052 1.0 0.2484 5.00 
17.133 0.024 1.0 0.1147 7.04 
28.700 0.012 1.0 0.0573 8.42 
34.300 0.010 1.0 0.0478 8.77 
 
Table A.99 Raw pH Data 
Time 0.00 1.08 2.82 3.78 4.52 5.23 5.43 6.57 9.87 18.48 34.30 35.92 
pH 7.96 8.09 8.10 8.07 8.06 8.04 8.01 7.99 7.98 7.99 8.00 8.01 
 
Table A.100 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC TNTC 52 5 715000 1.000000 0.00 0.00 
1 3.13   TNTC TNTC 92 11   126500 0.176923 -0.75 2.83 
2 6.25   TNTC 193 28     26538 0.037115 -1.43 4.16 
3 9.72 TNTC TNTC 80       11000 0.015385 -1.81 5.33 
4 18.17 TNTC 100 10       1375 0.001923 -2.72 7.22 
5 29.78 86 19 3       118 0.000165 -3.78 8.50 






Figure A.49 Chlorine vs. Time Graph 
	













































Table A.101 Experimental Conditions 
27-Aug-18  Date 
15  Temperature (˚C) 
8.00  pH 
150 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.102 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.19 2.0 1.8156 0.00 
0.450 0.158 2.0 1.5098 0.75 
1.817 0.085 2.0 0.8122 2.28 
4.268       3.49 
5.933 0.068 1.0 0.3249 4.06 
13.667 0.027 1.0 0.1290 6.03 
21.733 0.014 1.0 0.0669 7.27 
29.633 0.010 1.0 0.0478 8.01 
33.350 0.010 1.0 0.0478 8.24 
36.583 0.009 1.0 0.0430 8.41 
 
Table A.103 Raw pH Data 
Time 0.00 1.82 4.27 4.83 5.20 5.93 7.63 8.18 8.82 9.68 10.67 12.00 12.32 12.95 13.67 14.77 38.18 
pH 7.96 8.11 8.09 8.07 8.05 8.03 7.89 7.86 7.84 7.90 8.07 8.08 8.07 8.04 8.02 8.01 8.02 
 
Table A.104 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC TNTC 60 7 825000 1.000000 0.00 0.00 
1 2.78     TNTC TNTC TNTC     
  
2.92 
2 6.93   TNTC 209 23 2   28738 0.034833 -1.46 4.37 
3 15.03   TNTC 41 56     5638 0.006833 -2.17 6.29 
4 22.93 TNTC 197 16       2709 0.003283 -2.48 7.41 
5 30.72 TNTC 149 15       2049 0.002483 -2.60 8.08 
6 34.52 TNTC 100         1375 0.001667 -2.78 8.31 
7 38.00 TNTC 76         1045 0.001267 -2.90 8.47 
 
Note: The agar did not adhere to the flask for control sample dilutions -3 and -4. These 
flasks were tilted and moved as little as possible to prevent agar from moving. The agar did not 
completely cover the bottom of flasks for all control samples and sample 1 dilution -2.  
	 86	
	
Figure A.51 Chlorine vs. Time Graph 
	













































Table A.105 Experimental Conditions 
13-Aug-18  Date 
05  Temperature (˚C) 
8.00  pH 
300 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.106 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0 0.269 3.0 3.8557 0.00 
0.317 0.187 4.0 3.5738 1.18 
2.050 0.146 4.0 2.7903 6.70 
2.944       9.03 
6.017 0.122 4.0 2.3316 16.70 
11.550 0.104 4.0 1.9876 29.41 
15.417 0.101 4.0 1.9302 37.52 
19.267 0.092 4.0 1.7582 45.01 
22.45 0.088 4.0 1.6818 50.80 
 
Table A.107 Raw pH Data 























Table A.108 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC TNTC 84 11 1155000 1.000000 0.00 0.00 







Figure A.53 Chlorine vs. Time Graph 
	
















































Table A.109 Experimental Conditions 
22-Aug-18  Date 
05  Temperature (˚C) 
8.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.110 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.209 2.0 1.9971 0.00 
0.417 0.197 2.0 1.8825 0.81 
1.550 0.159 2.0 1.5194 2.72 
2.843       4.48 
3.833 0.124 2.0 1.1849 5.82 
6.550 0.104 2.0 0.9938 9.18 
9.683 0.089 2.0 0.8505 12.55 
12.283 0.080 2.0 0.7645 15.00 
14.633 0.074 2.0 0.7071 16.96 
 
Table A.111 Raw pH Data 
Time 0.00 1.55 2.52 4.58 5.95 6.55 10.93 16.70 
pH Fluctuate around 7.95 8.23 8.12  Fluctuate around 8 8.05 8.01 7.99 8.00 
 
Table A.112 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0     TNTC 287 37 7 451688 1.000000 0.00 0.00 
1 2.52   TNTC TNTC 96 10   132000 0.292237 -0.53 4.07 
2 4.90   TNTC 166 14 1   22825 0.050533 -1.30 7.19 
3 7.55 TNTC TNTC 51 9     7013 0.015525 -1.81 10.31 
4 10.65 TNTC 142 16       1953 0.004323 -2.36 13.50 
5 13.42 85 49 3       395 0.000875 -3.06 15.97 






Figure A.55 Chlorine vs. Time Graph 
	














































Table A.113 Experimental Conditions 
03-Sept-18  Date 
05  Temperature (˚C) 
8.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.114 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.239 2.0 2.2838 0.00 
0.333 0.191 2.0 1.8251 0.69 
1.767 0.142 2.0 1.3569 3.02 
2.947       4.38 
4.983 0.101 2.0 0.9651 6.53 
8.717 0.079 2.0 0.7549 10.03 
14.383 0.058 2.0 0.5542 14.40 
19.267 0.050 2.0 0.4778 17.42 
23.367 0.044 2.0 0.4204 19.53 
28.433 0.037 2.0 0.3536 21.68 
 
Table A.115 Raw pH Data 
Time 0.00 0.33 1.77 Approx. 6 12.00 12.20 15.75 22.00 26.22 30.82 
pH 
Fluctuate 













Table A.116 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 48 9 660000 1.000000 0.00 0.00 
1 2.88     TNTC 73 6   100375 0.152083 -0.82 4.32 
2 6.20   TNTC 99 17     13613 0.020625 -1.69 7.73 
3 9.93 TNTC 104 15 3     1430 0.002167 -2.66 11.06 





Figure A.57 Chlorine vs. Time Graph 
	














































Table A.117 Experimental Conditions 
05-Sept-18  Date 
25  Temperature (˚C) 
7.00  pH 
100 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.118 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.222 1.0 1.0607 0.00 
0.333 0.130 1.0 0.6211 0.28 
1.617 0.054 1.0 0.2580 0.85 
2.829       1.04 
3.850 0.018 1.0 0.0860 1.18 
6.850 0.009 1.0 0.0430 1.47 
8.833 0.006 1.0 0.0287 1.60 
10.767 0.006 1.0 0.0287 1.69 
 
Table A.119 Raw pH Data 
Time 0.00 0.45 0.87 1.75 4.50 6.45 8.42 12.10 
pH Fluctuate around 7 7.09 6.95 7.01 6.93 6.96 Fluctuate around 7 6.99 
 
Table A.120 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 69 2 948750 1.000000 0.00 0.00 
1 1.13   TNTC TNTC 66 5   90750 0.095652 -1.02 0.70 
2 2.95 TNTC TNTC 76 8     10450 0.011014 -1.96 1.06 
3 5.10 TNTC TNTC 46 5     6325 0.006667 -2.18 1.32 
4 7.48 TNTC 302 31 2     4153 0.004377 -2.36 1.52 
5 9.20 TNTC 237 25       3259 0.003435 -2.46 1.62 






Figure A.59 Chlorine vs. Time Graph 
	











































Table A.121 Experimental Conditions 
24-Sept-18  Date 
25  Temperature (˚C) 
7.00  pH 
120 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.122 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0 0.148 2.0 1.4142 0.00 
0.417 0.158 1.0 0.7549 0.44 
1.583 0.083 1.0 0.3966 1.15 
2.005       1.28 
3.233 0.044 1.0 0.2102 1.77 
6.267 0.018 1.0 0.0860 2.48 
8.750 0.011 1.0 0.0526 2.77 
 
Table A.123 Raw pH Data 
Time 0.00 1.58 3.23 6.27 10.45 
pH 6.96 6.99 7.00 7.04 7.05 
 
Table A.124 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 54 21 742500 1.000000 0.00 0.00 
1 2.60 170 103 4 0 0   825 0.001111 -2.95 1.54 








Figure A.61 Chlorine vs. Time Graph 
	












































Table A.125 Experimental Conditions 
02-Oct-18  Date 
25  Temperature (˚C) 
7.00  pH 
120 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.126 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0 0.154 2.0 1.4716 0.00 
0.283 0.170 1.0 0.8122 0.32 
1.700 0.066 1.0 0.3153 1.14 
2.470       1.31 
3.200 0.033 1.0 0.1577 1.49 
5.200 0.017 1.0 0.0812 1.87 
9.483 0.009 1.0 0.0430 2.32 
 
Table A.127 Raw pH Data 
Time 0.00 3.20 7.92 8.28 10.50 
pH Approx. 7 Approx. 7 7.07 7.01 6.98 
 
Table A.128 Raw Virus Data 
Time Viability at 10^-x dilution N N/No Log N/No CT 
[min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
0       TNTC 93 6 1278750 1.000000 0.00 0.00 
2.53 TNTC 192 45 7 0   4414 0.003452 -2.46 1.33 
4.03 TNTC 81 28 2     1114 0.000871 -3.06 1.67 
6.12 145 33 28 0     327 0.000255 -3.59 2.00 







Figure A.63 Chlorine vs. Time Graph 
	












































Table A.129 Experimental Conditions 
29-Aug-18  Date 
15  Temperature (˚C) 
7.00  pH 
120 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.130 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.155 2.0 1.4811 0.00 
0.450 0.100 2.0 0.9556 0.57 
1.983 0.102 2.0 0.9747 2.05 
4.167 0.075 1.0 0.3583 3.30 
5.550 0.060 1.0 0.2867 3.77 
8.176       4.28 
10.683 0.028 1.0 0.1338 4.75 
16.717 0.016 1.0 0.0764 5.66 
20.833 0.012 1.0 0.0573 6.13 
26.333 0.010 1.0 0.0478 6.62 
32.033 0.009 1.0 0.0430 7.00 
 











12 20.00 24.00 29.2 29.23 32 34.65 






7 7.01-7.04 7.08 
Approx. 
7 7.03 7.08 
 
Table A.132 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 52 5 715000 1.000000 0.00 0.00 






Figure A.65 Chlorine vs. Time Graph 
	












































Table A.133 Experimental Conditions 
10-Sept-18  Date 
15  Temperature (˚C) 
7.00  pH 
100 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.134 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.263 1.0 1.2566 0.00 
0.350 0.165 1.0 0.7883 0.35 
2.233 0.078 1.0 0.3727 1.48 
2.851       1.68 
4.417 0.044 1.0 0.2102 2.29 
7.083 0.025 1.0 0.1194 3.00 
10.383 0.014 1.0 0.0669 3.52 
12.650 0.010 1.0 0.0478 3.74 
 
Table A.135 Raw pH Data 
Time 0.00 4.42 8.23 10.38 13.85 
pH 6.97 6.99 6.99 7.02 7.05 
 
Table A.136 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 79 5 1086250 1.000000 0.00 0.00 
1 1.57     TNTC 61 97   83875 0.077215 -1.11 1.20 
2 5.60   TNTC 107 2 0   14713 0.013544 -1.87 2.65 
3 8.08   142 39 1 0   3658 0.003367 -2.47 3.19 
4 11.38 TNTC 115 10 2     1581 0.001456 -2.84 3.63 







Figure A.67 Chlorine vs. Time Graph 
	












































Table A.137 Experimental Conditions 
17-Sept-18  Date 
15  Temperature (˚C) 
7.00  pH 
120 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.138 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.188 2.0 1.7965 0.00 
0.400 0.103 2.0 0.9842 0.55 
1.800 0.061 2.0 0.5829 1.73 
2.017       1.84 
4.100 0.070 1.0 0.3344 3.06 
5.983 0.054 1.0 0.2580 3.85 
7.850 0.036 1.0 0.1720 4.40 
9.900 0.026 1.0 0.1242 4.84 
11.950 0.020 1.0 0.0956 5.14 
 
Table A.139 Raw pH Data 
Time 0.00 0.40 2.93 5.23 7.85 8.77 10.85 13.95 
pH 6.97 7.02 6.99 6.99 7.01 7.00 7.00 7.02 
 
Table A.140 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       239 47 3 487438 1.000000 0.00 0.00 
1 2.72   242 45 5 0   4758 0.009760 -2.01 2.30 
2 5.02 178 41 2 0     404 0.000829 -3.08 3.48 
3 6.95 93 54 0 0     435 0.000893 -3.05 4.16 







Figure A.69 Chlorine vs. Time Graph 
	













































Table A.141 Experimental Conditions 
10-Sept-18  Date 
5  Temperature (˚C) 
7.00  pH 
150 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.142 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.194 2.0 1.8538 0.00 
0.250 0.152 2.0 1.4525 0.41 
1.650 0.109 2.0 1.0416 2.22 
2.528     0.0000 3.01 
4.500 0.076 2.0 0.7262 4.72 
7.567 0.058 2.0 0.5542 6.97 
11.300 0.044 2.0 0.4204 9.15 
15.017 0.067 1.0 0.3201 10.85 
18.917 0.054 1.0 0.2580 12.23 
23.400 0.043 1.0 0.2054 13.43 
 
Table A.143 Raw pH Data 













7.01-7.02 7.01 7.03 7.04 
 
Table A.144 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 52 4 715000 1.000000 0.00 0.00 
1 2.65     136 12 0   18700 0.026154 -1.58 3.12 





Figure A.71 Chlorine vs. Time Graph 
	













































Table A.145 Experimental Conditions 
17-Sept-18  Date 
5  Temperature (˚C) 
7.00  pH 
150 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.146 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.193 2.0 1.8442 0.00 
0.350 0.151 2.0 1.4429 0.58 
1.700 0.107 2.0 1.0225 2.28 
2.341     0.0000 2.86 
4.000 0.075 2.0 0.7167 4.38 
6.317 0.065 2.0 0.6211 6.22 
8.350 0.055 2.0 0.5256 7.59 
10.367 0.047 2.0 0.4491 8.76 
 
Table A.147 Raw pH Data 
Time 0.00 1.70 2.95 4.00 6.32 9.32 11.67 
pH 6.95 7.05 7.02 7.00 7.00 7.00 7.01 
 
Table A.148 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       329 152 4 452375 1.000000 0.00 0.00 
1 2.95   TNTC 128 54 5   45925 0.101520 -0.99 3.44 
2 5.18 TNTC 100 9 3     1375 0.003040 -2.52 5.36 
3 7.35 163 18 2 0     224 0.000495 -3.31 6.94 







Figure A.73 Chlorine vs. Time Graph 
	













































Table A.149 Experimental Conditions 
24-Sept-18  Date 
5  Temperature (˚C) 
7.00  pH 
150 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.150 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.190 2.0 1.8156 0.00 
0.367 0.137 2.0 1.3091 0.57 
1.967 0.106 2.0 1.0129 2.53 
2.415       2.95 
3.950 0.085 2.0 0.8122 4.47 
5.717 0.071 2.0 0.6785 6.02 
7.650 0.064 2.0 0.6116 7.52 
11.050 0.051 2.0 0.4873 9.72 
 
Table A.151 Raw pH Data 
Time 0.00 0.50 1.97 3.95 4.83 5.72 7.65 12.93 
pH 6.97 7.05 7.01 6.97 6.96 6.97 6.99 7.00 
 
Table A.152 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 34 7 467500 1.000000 0.00 0.00 
1 2.90   TNTC 121 8 0   16638 0.035588 -1.45 3.44 
2 4.83 TNTC 134 96 0     7521 0.016088 -1.79 5.27 







Figure A. 75 Chlorine vs. Time Graph 
	













































Table A.153 Experimental Conditions 
03-Oct-18  Date 
15  Temperature (˚C) 
9.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
1670 µL of CVB5 Stock Kelley 
 
Table A.154 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.227 2.0 2.1691 0.00 
0.350 0.196 2.0 1.8729 0.71 
1.833 0.159 2.0 1.5194 3.27 
2.926       4.76 
6.000 0.129 2.0 1.2327 8.67 
13.417 0.105 2.0 1.0033 17.23 
20.867 0.089 2.0 0.8505 24.73 
31.150 0.075 2.0 0.7167 33.52 
38.483 0.067 2.0 0.6402 38.84 
46.533 0.060 2.0 0.5733 43.90 
 
Table A.155 Raw pH Data 
Time 0.00 2.97 4.17 13.33 18.20 22.32 23.65 33.22 47.47 
pH Approx. 8.97 Approx. 9.00 9.03 9.03 8.99 9.01 8.98 8.97 8.94 
 
Table A.156 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 158 16 2172500 1.000000 0.00 0.00 
1 2.80   TNTC TNTC TNTC 51 8 701250 0.322785 -0.49 4.60 
2 7.03   TNTC TNTC 153 24   210375 0.096835 -1.01 9.93 
3 14.47 TNTC TNTC 91 10     12513 0.005759 -2.24 18.35 






Figure A.77 Chlorine vs. Time Graph 
	














































Table A.157 Experimental Conditions 
10-Oct-18  Date 
15  Temperature (˚C) 
9.00  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
1670 µL of CVB5 Stock Kelley 
 
Table A.158 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.234 2.0 2.2360 0.00 
0.333 0.234 2.0 2.2360 0.74 
1.683 0.163 2.0 1.5576 3.23 
2.597       4.52 
6.850 0.125 2.0 1.1945 9.99 
15.067 0.098 2.0 0.9365 19.24 
21.233 0.087 2.0 0.8313 25.16 
25.283 0.082 2.0 0.7836 28.65 
28.800 0.077 2.0 0.7358 31.43 
 
Table A.159 Raw pH Data 
Time 0.00 0.00 3.00 4.50 17.62 23.42 30.30 
pH Approx. 8.96 Approx. 8.98 Approx. 9.00 Fluctuate around 8.95-9.07 9.03 9.01 9.01 
 
Table A.160 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 83 28 1141250 1.000000 0.00 0.00 
1 2.62       TNTC 58 4 797500 0.698795 -0.16 4.55 
2 7.88     TNTC 153 27   210375 0.184337 -0.73 11.25 
3 16.08   159 23 3     2186 0.001916 -2.72 20.27 
4 22.32 83 17 7       114 0.000100 -4.00 26.12 






Figure A.79 Chlorine vs. Time Graph 
	














































Table A.161 Experimental Conditions 
17-Oct-18  Date 
15  Temperature (˚C) 
9.00  pH 
300 
Virus 
 Volume of Chlorine Stock Added (µL) 
1670 µL of CVB5 Stock Kelley 
 
Table A.162 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.225 3.0 3.2250 0.00 
0.500 0.190 3.0 2.7234 1.49 
1.933 0.169 3.0 2.4224 5.26 
2.546       6.66 
6.517 0.146 3.0 2.0927 15.47 
10.750 0.134 3.0 1.9207 24.30 
16.233 0.124 3.0 1.7774 34.93 
19.100 0.121 3.0 1.7344 40.15 
 
Table A.163 Raw pH Data 
Time 0.00 0.50 3.32 5.72 7.75 12.70 20.42 
pH 8.97 9.00 9.04 9.01 9.01 9.01 9.01 
 
Table A.164 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 127 9 1746250 1.000000 0.00 0.00 
1 2.90     TNTC TNTC 38 2 522500 0.299213 -0.52 7.47 
2 7.60   TNTC 144 26 0   19800 0.011339 -1.95 17.78 







Figure A.81 Chlorine vs. Time Graph 
	















































Table A.165 Experimental Conditions 
26-March-19  Date 
5  Temperature (˚C) 
9.50  pH 
500 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.166 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0 0.269 5.0 6.4262 0.00 
0.367 0.161 5.0 3.8462 2.30 
1.617 0.216 5.0 5.1601 9.33 
2.476       13.52 
3.100 0.198 5.0 4.7301 16.41 
6.217 0.193 5.0 4.6106 30.74 
11.100 0.183 5.0 4.3717 52.76 
26.033 0.159 5.0 3.7984 116.88 
38.817 0.159 5.0 3.7984 168.12 
50.833 0.152 5.0 3.6312 213.41 
63.867 0.146 5.0 3.4878 259.59 
 
Note: Chlorine sample taken at 0.367 min was excluded from analysis as inaccurate due 
to human error since the chlorine sample following it displayed higher absorbance. 
 
Table A.167 Raw pH Data 
Time 0.00 2.27 3.97 10.18 12.10 27.88 39.85 48.52 60.97 64.95 
pH 9.46 9.50 9.51 9.46 9.52 9.50 9.49 9.50 9.49 9.50 
 
Table A.168 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 89 8 1223750 1.000000 0.00 0.00 
1 5.10     TNTC 191 30   262625 0.214607 -0.67 25.63 
2 9.88   TNTC 275 47 15   51219 0.041854 -1.38 47.33 
3 24.85 244 56 2 0     553 0.000452 -3.35 111.97 
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Figure A.83 Chlorine vs. Time Graph 
	

















































Table A.169 Experimental Conditions 
01-April-19  Date 
25  Temperature (˚C) 
9.50  pH 
200 
Virus 
 Volume of Chlorine Stock Added (µL) 
500 µL of CVB5 Stock A 
 
Table A.170 Raw Free Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0 0.163 3.0 2.3364 0.00 
0.417 0.127 3.0 1.8204 0.92 
1.733 0.104 3.0 1.4907 3.26 
2.824       4.68 
6.233 0.075 3.0 1.0750 8.66 
11.367 0.173 1.0 0.8266 13.86 
19.233 0.130 1.0 0.6211 20.29 
25.917 0.105 1.0 0.5017 24.57 
33.967 0.083 1.0 0.3966 28.61 
43.667 0.063 1.0 0.3010 32.24 
 
Table A.171 Raw pH Data 
Time 0.00 2.85 4.28 5.33 7.32 13.68 17.53 22.77 28.50 42.60 45.57 
pH 9.47 9.46 9.48 9.51 9.49 9.49 9.47 9.52 9.49 9.51 9.49 
 
Table A.172 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 62 21 852500 1.000000 0.00 0.00 
1 2.73     TNTC 174 28   239250 0.280645 -0.55 4.58 
2 7.18     TNTC 42 7   57750 0.067742 -1.17 9.69 
3 12.40   TNTC 62 3     8525 0.010000 -2.00 14.80 
4 20.30   44 3 0     605 0.000710 -3.15 21.04 
5 26.95 151 31 1 0     208 0.000244 -3.61 25.15 





Figure A.85 Chlorine vs. Time Graph 
	














































APPENDIX B: RAW DATA OF COMBINED CHLORINE EXPERIMENTS 
 
Note: In CT vs. Time tables, the row highlighted in yellow is a theoretical CT value calculated at 
the time ammonia was added. In log(Inactivation) vs. CT tables, the rows highlighted in yellow 
are theoretical inactivation levels calculated at the time ammonia was added. 
 
Table B.1 Experimental Conditions 
21-Jan-19  Date 
15  Temperature (˚C) 







 Volume of Chlorine Stock Added (µL) 
Volume of Ammonia Stock Added (µL) 
3340 µL of CVB5 Stock Kelley 
100 mL total CBS, ammonia, and chlorine 
1670 µL of CVB5 Stock Kelley in 50 mL CBS 
Made in January 2019, m=0.2421 for monochloramine 
 
Note: Virus samples 1 and 7 were taken from Reactor C. 300 µL of quencher was added per 
virus sample since the monochloramine concentration was around 30 mg/L. The UV 2700 















Table B.2 Raw Combined Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.104 60.0 25.7745 0.00 
2.650 0.094 60.0 23.2962 66.25 
10.183 0.104 60.0 25.7745 254.57 
24.733 0.101 60.0 25.0310 618.28 
49.450 0.107 60.0 26.5180 1236.02 
68.967 0.091 60.0 22.5527 1723.72 
88.600 0.105 60.0 26.0223 2214.26 
 
Table B.3 Raw pH Data Reactor B 
Time 0.00 30.00 95.00 
pH 9.00 9.00 8.92 
	
Table B.4 Raw pH Data Reactor C 
Time 0.00 100.80 
pH 9.01 8.92 
	
nm.










Figure B.1 UV 2700 Absorbance Graph 
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Table B.5 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 51 11 828750 1.000000 0.00 0.00 
1 1.42     TNTC 232 32   377000 0.454902 -0.34 35.42 
2 8.85     TNTC 61 5   99125 0.119608 -0.92 221.24 
3 23.45   292 33 5     5054 0.006098 -2.21 586.20 
7 87.13     TNTC TNTC 73   1186250       
	
	


















































Table B.6 Experimental Conditions 
28-Jan-19  Date 
15  Temperature (˚C) 







 Volume of Chlorine Stock Added (µL) 
Volume of Ammonia Stock Added (µL) 
1670 µL of CVB5 Stock Kelley 
50 mL total CBS, ammonia, and chlorine 
1670 µL of CVB5 Stock Kelley in 47.5 mL CBS 
Made in January 2019, m=0.2421 for monochloramine 
	
Note: Virus samples 1 and 7 were taken from Reactor C. 300 µL of quencher was added per 
virus sample since the monochloramine concentration was around 30 mg/L. The UV 2700 




















Figure B.4 UV 2700 Absorbance Graph 
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Table B.7 Raw Combined Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.133 60.0 32.9616 0.00 
2.267 0.126 60.0 31.2268 72.26 
9.817 0.132 60.0 32.7138 312.32 
22.933 0.116 60.0 28.7485 727.05 
34.267 0.129 60.0 31.9703 1083.02 
42.117 0.131 60.0 32.4659 1328.30 
50.450 0.124 60.0 30.7311 1587.55 
	
Table B.8 Raw pH Data Reactor B 
Time 0.00 15.15 20.15 39.08 43.10 45.12 64.13 
pH 9.05 8.96 9.03 9.09 9.05 9.03 9.12 
	
Table B.9 Raw pH Data Reactor C 
Time 0.00 96.60 
pH 9.03 8.97 
	
Table B.10 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 60 5 975000 1.000000 0.00 0.00 
1 0.85     TNTC 110 27   178750 0.183333 -0.74 27.11 
2 8.32     TNTC 86 12   139750 0.143333 -0.84 264.70 
3 21.65   TNTC 79 7     12838 0.013167 -1.88 686.60 
4 32.90 304 123 14       1246 0.001278 -2.89 1040.21 
5 40.57 54 14 0       88 0.000090 -4.05 1279.95 




Figure B.5 Chlorine vs. Time Graph 
	






























































Note: Virus samples 1 and 7 were taken from Reactor C. 200 µL of quencher was added per 
virus sample since the monochloramine concentration was around 20 mg/L. The UV 2700 























Figure B.7 UV 2700 Absorbance Graph 
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Table B.12 Raw Combined Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.135 40.0 22.3048 0.00 
1.683 0.121 40.0 19.9917 34.31 
10.733 0.123 40.0 20.3222 217.86 
26.750 0.104 40.0 17.1830 538.90 
42.733 0.121 40.0 19.9917 854.48 
52.533 0.120 40.0 19.8265 1045.65 
68.683 0.119 40.0 19.6613 1356.87 
	
Table B.13 Raw pH Data Reactor B 
Time 0.00 20.13 21.93 23.78 58.33 78.95 
pH 9.05 8.94 8.97 8.99 9.03 9.05 
	
Table B.14 Raw pH Data Reactor C 
Time 0.00 81.80 
pH 9.02 8.97 
	
Table B.15 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 74 11 1110000 1.000000 0.00 0.00 
1 0.58     TNTC TNTC 101   1515000 1.364865 0.14 18.61 
2 9.45     TNTC 270 33   450000 0.405405 -0.39 300.68 
3 25.38   TNTC 225 28     33750 0.030405 -1.52 804.18 
4 41.48   TNTC 43 5     6450 0.005811 -2.24 1308.55 
5 51.13 TNTC 113 9       1695 0.001527 -2.82 1608.76 
6 66.85 37 5 1       56 0.000050 -4.30 2094.34 




Figure B.8 Chlorine vs. Time Graph 
	












































Table B.16 Experimental Conditions 
08-Mar-19  Date 
15  Temperature (˚C) 





 Volume of Chlorine Stock Added (µL) 
1670 µL of CVB5 Stock Kelley 
Made in February 2019, m=0.2263 for monochloramine 
Cell passage 
	
Note: The UV 2700 spectrometer showed no distinct peak, but there was a plateau around 243 
























Figure B.10 UV 2700 Absorbance Graph 
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Table B.17 Raw Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.186 8.0 7.1094 0.00 
0.350 0.176 8.0 6.7272 2.41 
1.467 0.170 8.0 6.4978 9.93 
3.650 0.164 8.0 6.2685 23.93 
6.683 Added 92.9 µL ammonia   
6.683       41.95 
7.367 0.180 8.0 6.3632 4.29 
22.533 0.178 8.0 6.2925 99.54 
70.083 0.177 8.0 6.2572 397.58 
84.117 0.176 8.0 6.2218 485.38 
159.833 0.181 8.0 6.3986 957.83 
191.183 0.180 8.0 6.3632 1152.82 
	




































8.93 8.96 8.99 9.04 8.81 8.99 8.97 9.00 9.00 
	
Table B.19 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 91 15 1251250 1.000000 0.00 0.00 
1 2.22     TNTC 53 1   72875 0.058242 -1.23 14.84 
2 4.75 56 7 2 0     77 0.000062 -4.21 30.65 
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Figure B.11 Chlorine vs. Time Graph 
	











































Table B.20 Experimental Conditions 
11-Mar-19  Date 
15  Temperature (˚C) 





 Volume of Chlorine Stock Added (µL) 
1670 µL of CVB5 Stock Kelley 
Made in February 2019, m=0.2263 for monochloramine 
Cell passage 
	
Note: The UV 2700 spectrometer showed no distinct peak, but there was a plateau around 243 

























Figure B.13 UV 2700 Absorbance Graph 
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Table B.21 Raw Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.000 0.21 8.0 8.0268 0.00 
0.367 0.192 8.0 7.3387 2.82 
1.383 0.170 8.0 6.4978 9.90 
          
3.750 Added 95.8 µL ammonia   
3.750       22.84 
5.133 0.182 8.0 6.4339 8.97 
33.200 0.188 8.0 6.6460 190.05 
74.067 0.187 8.0 6.6107 450.91 
130.417 0.153 8.0 5.4087 805.23 
132.483 0.189 8.0 6.6814 818.11 
138.700 0.193 8.0 6.8228 856.79 
141.483 0.192 8.0 6.787450287 874.09 
	
Table B.22 Raw pH Data 
Time 0.00 6.38 10.90 12.35 42.47 84.95 134.73 139.58 143.00 
pH 8.98 8.83 8.96 8.99 9.03 9.02 8.90 8.97 8.97 
	
Table B.23 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 91 15 1251250 1.000000 0.00 0.00 
1 2.17     TNTC 106 14   145750 0.116484 -0.93 14.69 




Figure B.14 Chlorine vs. Time Graph 
	


















































Table B.24 Experimental Conditions 
15-Mar-19  Date 
15  Temperature (˚C) 





 Volume of Chlorine Stock Added (µL) 
1670 µL of CVB5 Stock Kelley 
Made in February 2019, m=0.2263 for monochloramine 
Cell passage 
	
Note: The UV 2700 spectrometer showed no distinct peak, but there was a plateau around 243 

























Figure B.16 UV 2700 Absorbance Graph 
	 138	
	
Table B.25 Raw Chlorine Data 
Time Abs Dilution Cl2 CT 
[min]   Factor [mg/L] [mg*min/L] 
0.00 0.198 8.0 7.5681 0.00 
0.40 0.180 8.0 6.8801 2.90 
1.47 0.168 8.0 6.4214 10.07 
          
3.58 Added 94.7 µL ammonia   
3.58       22.19 
4.53 0.172 8.0 6.0804 27.96 
28.98 0.173 8.0 6.1158 176.27 
56.50 0.173 8.0 6.1158 342.66 
87.40 0.172 8.0 6.0804 528.83 
117.88 0.177 8.0 6.2572 711.81 
120.67 0.173 8.0 6.1158 728.49 
	
Table B.26 Raw pH Data 
Time 0.00 5.93 11.42 23.35 50.42 59.00 62.33 62.88 90.17 116.67 119.58 
pH 8.96 8.80 8.96 8.98 8.98 8.96 8.97 9.00 8.97 9.00 8.98 
	
Table B.27 Raw Virus Inactivation Data 
Sample Time Viability at 10^-x dilution N N/No Log N/No CT 
  [min] 0 -1 -2 -3 -4 -5 pfu/ml     [mg*min/L] 
Control 0       TNTC 169 18 2323750 1.000000 0.00 0.00 
1 2.27     TNTC 106 12   145750 0.062722 -1.20 14.96 
  3.58                 -1.78 22.19 
  3.58                 -2.69 22.19 
2 5.63 TNTC 189 13 1     2599 0.001118 -2.95 34.64 




Figure B.17 Chlorine vs. Time Graph 
	

























































APPENDIX C: ANALYSIS OF COMBINED CHLORINE EXPERIMENTS 
 
The results from the inactivation experiments with monochloramine can be seen in 
Appendix B. It was observed that CVB5 is much more resistant to monochloramine than free 
chlorine (see Figures C.1 and C.2). While significant discrepancy can be seen among the three 
tests with monochloramine, they consistently display greater resistance than the experiments 
performed under similar conditions with free chlorine. The average inactivation coefficient of 
CVB5 with monochloramine at 15˚C and pH 9 was -0.00291 (L/mg min). This is nearly a 
magnitude of 50 times less than the inactivation coefficient under similar conditions with free 
chlorine, -0.141 (L/mg min).  
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Figure C.2 Inactivation of CVB5 with Monochloramine at 15˚C pH 9, CVB5 Stock Kelley 
 
The inactivation experiment that started with free chlorine and switched to 
monochloramine (which was the only combined chlorine species present) also showed greater 
resistance to monochloramine than free chlorine (see Figure C.3). This was seen by the fivefold 
decrease in the inactivation coefficient from the free chlorine exposure period to the 
monochloramine exposure period. However, the monochloramine inactivation coefficient from 
this experiment (-0.0207 L/mg min) was nearly ten times greater than the inactivation coefficient 
from when CVB5 was only exposed to monochloramine (-0.00291 L/mg min). This indicates 
that the exposure to free chlorine reduces CVB5’s resistance to monochloramine. This concept 
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Figure C.3 Sequential Inactivation of CVB5 with Free/Combined Chlorine at 15˚C pH 9,  
CVB5 Stock Kelley 
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